261 related articles for article (PubMed ID: 21598212)
1. TP53 codon 72 polymorphism and P53 protein expression in colorectal cancer specimens in Isfahan.
Dastjerdi MN
Acta Med Iran; 2011; 49(2):71-7. PubMed ID: 21598212
[TBL] [Abstract][Full Text] [Related]
2. Association of the p53 codon 72 polymorphism with clinicopathological characteristics of colorectal cancer through mRNA analysis.
De Oliveira LP; López I; Dos Santos EM; Tucci P; Marín M; Soares FA; Rossi BM; Coudry Rde A
Oncol Rep; 2014 Mar; 31(3):1396-406. PubMed ID: 24366026
[TBL] [Abstract][Full Text] [Related]
3. TP53 R72P and MDM2 SNP309 polymorphisms and colorectal cancer risk: the Fukuoka Colorectal Cancer Study.
Joshi AM; Budhathoki S; Ohnaka K; Mibu R; Tanaka M; Kakeji Y; Maehara Y; Okamura T; Ikejiri K; Futami K; Maekawa T; Yasunami Y
Jpn J Clin Oncol; 2011 Feb; 41(2):232-8. PubMed ID: 21051533
[TBL] [Abstract][Full Text] [Related]
4. [Role of the genetic polymorphism of p53 (codon 72) gene in colorectal cancer].
Lima JM; Serafim PV; Silva ID; Forones NM
Arq Gastroenterol; 2006; 43(1):8-13. PubMed ID: 16699611
[TBL] [Abstract][Full Text] [Related]
5. Identification of colorectal cancer patients with tumors carrying the TP53 mutation on the codon 72 proline allele that benefited most from 5-fluorouracil (5-FU) based postoperative chemotherapy.
Godai TI; Suda T; Sugano N; Tsuchida K; Shiozawa M; Sekiguchi H; Sekiyama A; Yoshihara M; Matsukuma S; Sakuma Y; Tsuchiya E; Kameda Y; Akaike M; Miyagi Y
BMC Cancer; 2009 Dec; 9():420. PubMed ID: 19954513
[TBL] [Abstract][Full Text] [Related]
6. p53 codon 72 polymorphism in patients with gastric and colorectal cancer in a Korean population.
Song HR; Kweon SS; Kim HN; Piao JM; Yun WJ; Choi JS; Hwang JE; Yoon JY; Kim HR; Park YK; Kim SH; Choi YD; Shin MH
Gastric Cancer; 2011 Aug; 14(3):242-8. PubMed ID: 21461655
[TBL] [Abstract][Full Text] [Related]
7. p53 codon 72 proline/arginine polymorphism and autoimmune thyroid diseases.
Chen RH; Chang CT; Wang TY; Huang WL; Tsai CH; Tsai FJ
J Clin Lab Anal; 2008; 22(5):321-6. PubMed ID: 18803266
[TBL] [Abstract][Full Text] [Related]
8. Association of the TP53 codon 72 polymorphism with colorectal cancer in a Chinese population.
Zhu ZZ; Wang AZ; Jia HR; Jin XX; He XL; Hou LF; Zhu G
Jpn J Clin Oncol; 2007 May; 37(5):385-90. PubMed ID: 17599946
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of p53 codon 72 polymorphism in adenocarcinomas of the colon and rectum in La Plata, Argentina.
Pérez LO; Abba MC; Dulout FN; Golijow CD
World J Gastroenterol; 2006 Mar; 12(9):1426-9. PubMed ID: 16552814
[TBL] [Abstract][Full Text] [Related]
10. p 53 codon 72 polymorphism in stomach and colorectal adenocarcinomas in Iranian patients.
Mojtahedi Z; Haghshenas MR; Hosseini SV; Fattahi MJ; Ghaderi A
Indian J Cancer; 2010; 47(1):31-4. PubMed ID: 20071787
[TBL] [Abstract][Full Text] [Related]
11. Association of P53 codon 72 polymorphism and lung cancer in an ethnic Iranian population.
Eydian Z; Asna'ashari AM; Behravan J; Sharifi-Rad J; Entezari Heravi R
Cell Mol Biol (Noisy-le-grand); 2016 Aug; 62(9):34-8. PubMed ID: 27585259
[TBL] [Abstract][Full Text] [Related]
12. TP53 mutation, allelism and survival in non-small cell lung cancer.
Nelson HH; Wilkojmen M; Marsit CJ; Kelsey KT
Carcinogenesis; 2005 Oct; 26(10):1770-3. PubMed ID: 15905205
[TBL] [Abstract][Full Text] [Related]
13. Deficient DNA mismatch repair is associated with favorable prognosis in Thai patients with sporadic colorectal cancer.
Korphaisarn K; Pongpaibul A; Limwongse C; Roothumnong E; Klaisuban W; Nimmannit A; Jinawath A; Akewanlop C
World J Gastroenterol; 2015 Jan; 21(3):926-34. PubMed ID: 25624727
[TBL] [Abstract][Full Text] [Related]
14. Arginine homozygosity in codon 72 of p53 correlates with failure to imatinib response in chronic myeloid leukemia.
Camelo-Santos J; do Prado Barbosa A; de Paula Silveira-Lacerda E; Guillo LA
Biomed Pharmacother; 2013 Mar; 67(2):103-7. PubMed ID: 23433851
[TBL] [Abstract][Full Text] [Related]
15. Association of TP53 codon 72 polymorphism with cervical cancer risk in Chinese women.
Jiang P; Liu J; Zeng X; Li W; Tang J
Cancer Genet Cytogenet; 2010 Mar; 197(2):174-8. PubMed ID: 20193851
[TBL] [Abstract][Full Text] [Related]
16. TP53 codon 72 Arg/Arg polymorphism is associated with a higher risk for inflammatory bowel disease development.
Volodko N; Salla M; Eksteen B; Fedorak RN; Huynh HQ; Baksh S
World J Gastroenterol; 2015 Sep; 21(36):10358-66. PubMed ID: 26420962
[TBL] [Abstract][Full Text] [Related]
17. Arginine and proline alleles of the p53 gene are associated with different locations of gastric cancer.
Lai KC; Chen WC; Tsai FJ; Li SY; Jeng LB
Hepatogastroenterology; 2005; 52(63):944-8. PubMed ID: 15966238
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism of TP53 codon 72 showed no association with breast cancer in Iranian women.
Khadang B; Fattahi MJ; Talei A; Dehaghani AS; Ghaderi A
Cancer Genet Cytogenet; 2007 Feb; 173(1):38-42. PubMed ID: 17284368
[TBL] [Abstract][Full Text] [Related]
19. Allelic polymorphism in codon 72 of p53 gene: prognosis value, survival rates, and their association with breast cancer.
Golmohammadi R; Namazi MJ
Eur J Gynaecol Oncol; 2016 Aug; 37(4):493-498. PubMed ID: 29894073
[TBL] [Abstract][Full Text] [Related]
20. TP53 Gene Pro72Arg (rs1042522) Single Nucleotide Polymorphism as Not a Risk Factor for Colorectal Cancer in the Iranian Azari Population.
Asadi M; Shanehbandi D; Zarintan A; Pedram N; Baradaran B; Zafari V; Shirmohamadi M; Hashemzadeh S
Asian Pac J Cancer Prev; 2017 Dec; 18(12):3423-3427. PubMed ID: 29286614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
